Craft

Ventripoint Diagnostics

Stock Price

$0.1

2024-10-29

Market Capitalization

$17.6 M

2024-10-29

Revenue

$95 K

FY, 2024

Ventripoint Diagnostics Summary

Company Summary

Overview
Ventripoint Diagnostics is a medical device company engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. The company develops the Knowledge Based Reconstruction (KBR) algorithm that allows for the creation of a 3D model of all chambers of the heart, right and left ventricles and right and left atria, using images generated from existing 2D and 4D imaging equipment. Its technology platform is applicable to all heart diseases for adults and pediatrics.
Type
Public
Status
Active
Founded
2005
HQ
Toronto, CA | view all locations
Website
https://www.ventripoint.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Toronto, ON HQ

    Canada

    100 Sheppard Ave E Suite 605, North York

Ventripoint Diagnostics Financials

Summary Financials

Revenue (Q3, 2025)
$C105.0K
Gross profit (Q3, 2025)
$C105.0K
Net income (Q3, 2025)
($C752.0K)
Cash (Q3, 2025)
$C68.0K
EBIT (Q3, 2025)
($C634.0K)
Enterprise value
$19.8M

Footer menu